Impact of Tranexamic Acid Use in Percutaneous Nephrolithotomy

• Status: Unknown status
• Trial end date: 2019-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is a double blinded randomized controlled trial evaluating the impact of tranexamic acid use on the transfusion rate in patients with complex kidney stones undergoing percutaneous nephrolithotomy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Sao Paulo
• Collaborator: Fundação de Amparo à Pesquisa do Estado de São Paulo
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Complex kidney stone (staghorn calculi GUYS III and IV)

Exclusion Criteria:

• Coronary artery disease - stent

• Severe chronic renal failure

• Congenital or acquired thrombophilia/thrombosis event

• Known or suspected allergy